Uptake of monoamines into central neurones and the blood‐brain barrier in the infant rat

1 . A fluorescence histochemical study was undertaken to investigate the ability of systemically administered monoamines to penetrate into the central nervous system of infant rats. 2 . It was found that after subcutaneous injections of large doses, l‐noradrenaline, l‐α‐methyl‐noradrenaline, dl‐α‐methyl‐dopamine, l‐α‐methyl‐dopa and 5‐hydroxytryptamine could cross the blood‐brain barrier of newborn to 2 week old rats and be taken up by neurones normally containing monoamine as well as by several neurones which normally contained no monoamine. 3 . 5‐Hydroxytryptamine containing neurones took up 5‐hydroxytryptamine as well as catecholamines and α‐methyl‐dopa. The pinealocytes, which contain large amounts of 5‐hydroxytryptamine, were depleted of their endogenous fluorescence by α‐methyl‐dopa and showed no selective uptake of catecholamines. 4 . The uptake of monoamines was not antagonized by previous reserpine treatment or by inhibition of catecholamine synthesis, and occurred throughout the whole extent of the monoamine‐containing neurones (cell body, axon, terminals). 5 . The monoamines were also taken up by the endothelial cells and pericytes of capillaries in the central nervous system (CNS) which are thought to constitute the physical barrier to these substances in the adult. 6 . The peripheral sympathetic nerves to pial blood vessels, the pineal and pituitary glands also took up the monoamines and α‐methyl‐dopa; uptake was also noted in cells of the pituitary gland, in epithelial and connective tissue elements of the meninges and choroid plexuses and in the epithelial, connective and muscular tissue of pial blood vessels. 7 . It is concluded that the blood‐brain barrier to monoamines may not be fully developed in infant rats, at least for high levels of circulating monoamines; the central monoamine‐containing neurones possess the ‘membrane pump’ mechanism for uptake of monoamines from the time of birth, even though they are not fully developed morphologically.

[1]  M. Henning Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats. , 2009, Acta pharmacologica et toxicologica.

[2]  Å. Bertler,et al.  THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES. , 2009, Acta pharmacologica et toxicologica.

[3]  L. Seiden,et al.  Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response. , 1969, The Journal of pharmacology and experimental therapeutics.

[4]  M. Misrabi Intranuclear inclusions in neurones and glial cells in the spinal cord of foetal, neonatal and adult rats. , 1969, Journal of anatomy.

[5]  U. Ungerstedt,et al.  Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. , 1968, European journal of pharmacology.

[6]  M. Bulat,et al.  Mechanism of 5-Hydroxytryptamine Penetration through the Cerebrospinal Fluid–Brain Barrier , 1968, Nature.

[7]  M. Bulat,et al.  PASSAGE OF 5‐HYDROXYTRYPTAMINE THROUGH THE BLOOD‐BRAIN BARRIER, ITS METABOLISM IN THE BRAIN AND ELIMINATION OF 5‐HYDROXYINDO‐LEACETIC ACID FROM THE BRAIN TISSUE , 1968, Journal of neurochemistry.

[8]  C. Owman,et al.  Activities of tryptophan hydroxylase, dopa decarboxylase, and monoamine oxidase as correlated with the appearance of monoamines in developing rat pineal gland. , 1967, Life sciences.

[9]  K. Fuxe,et al.  The effect of drugs on accumulation of monoamines in tubero-infundibular dopamine neurons , 1967 .

[10]  E. Rosengren,et al.  DOPAMINE FORMATION IN BRAIN CAPILLARIES—AN ENZYMIC BLOOD–BRAIN BARRIER MECHANISM , 1967, Journal of neurochemistry.

[11]  W. Lichtensteiger,et al.  UPTAKE OF 5‐HYDROXYTRYPTAMINE AND 5‐HYDROXYTRYPTOPHAN BY NEURONS OF THE CENTRAL NERVOUS SYSTEM NORMALLY CONTAINING CATECHOLAMINES * , 1967, Journal of neurochemistry.

[12]  W. Lichtensteiger Uptake of Norepinephrine in Periglomerular Cells of the Olfactory Bulb of the Mouse , 1966, Nature.

[13]  W. Lichtensteiger,et al.  Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons. , 1966, The Journal of pharmacology and experimental therapeutics.

[14]  Å. Bertler,et al.  The localization of monoaminergic blood-brain barrier mechanisms. , 1966, Pharmacological reviews.

[15]  J. Glowinski,et al.  METABOLISM OF [3H]NOREPINEPHRINE IN THE RAT BRAIN , 1965, Journal of neurochemistry.

[16]  K. Fuxe,et al.  UPTAKE OF L-DOPA AND NORADRENALINE BY CENTRAL CATECHOLAMINE NEURONS. , 1964, Life sciences.

[17]  C J CLEMEDSON,et al.  DYNAMIC RESPONSE OF CHEST WALL AND LUNG INJURIES IN RABBITS EXPOSED TO AIR SHOCK WAVES OF SHORT DURATION. , 1964, Acta physiologica Scandinavica. Supplementum.

[18]  J. Glowinski,et al.  PHYSIOLOGICAL DISPOSITION OF H3-NOREPINEPHRINE IN THE DEVELOPING RAT. , 1964, The Journal of pharmacology and experimental therapeutics.

[19]  J. Axelrod,et al.  THE UPTAKE OF CIRCULATING [3H]NOREPINEPHRINE BY THE PITUITARY GLAND AND VARIOUS AREAS OF THE BRAIN , 1961, Journal of neurochemistry.

[20]  S. Smith THE PHARMACOLOGICAL ACTIONS OF 3,4‐DIHYDROXY‐PHENYL‐α‐METHYLALANINE (α‐METHYLDOPA), AN INHIBITOR OF 5‐HYDROXYTRYPTOPHAN DECARBOXYLASE , 1960 .

[21]  J. Axelrod,et al.  The physiological disposition of H3-epinephrine and its metabolite metanephrine. , 1959, The Journal of pharmacology and experimental therapeutics.

[22]  L. Loizou The development of monoamine-containing neurones in the brain of the albino rat. , 1969, Journal of anatomy.

[23]  B. Hamberger Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. A histochemical study. , 1967, Acta physiologica Scandinavica. Supplementum.

[24]  P. Lundborg Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues. , 1967, Acta physiologica Scandinavica. Supplementum.

[25]  L. Olson,et al.  Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. , 1967, Acta physiologica Scandinavica.

[26]  C. Owman,et al.  A DETAILED METHODOLOGICAL DESCRIPTION OF THE FLUORESCENCE METHOD FOR THE CELLULAR DEMONSTRATION OF BIOGENIC MONOAMINES , 1965 .

[27]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.